AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 175 filers reported holding AMYLYX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,515,868 | $46,065,543 | 15.30% |
| Alpha Wave Global, LP | 853,262 | $15,623,227 | 9.88% |
| Saturn V Capital Management LP | 886,143 | $16,225,278 | 6.79% |
| Ally Bridge Group (NY) LLC | 272,690 | $4,992,954 | 5.86% |
| Altium Capital Management LP | 534,700 | $9,790,357 | 5.11% |
| Boxer Capital, LLC | 2,084,000 | $38,158,040 | 2.03% |
| Octagon Capital Advisors LP | 695,000 | $12,725,450 | 1.96% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 295,000 | $5,398,500 | 1.82% |
| Tri Locum Partners LP | 282,862 | $5,179,203 | 1.66% |
| Perceptive Advisors | 2,688,873 | $49,233,265 | 1.64% |
| AlphaCentric Advisors LLC | 145,500 | $2,664,105 | 1.51% |
| Ghost Tree Capital, LLC | 215,000 | $3,936,650 | 1.30% |
| Avidity Partners Management LP | 1,756,940 | $32,169,571 | 1.30% |
| Deep Track Capital, LP | 1,259,335 | $23,058,424 | 0.89% |
| Rock Springs Capital Management LP | 1,545,016 | $28,289,243 | 0.76% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 681,310 | $12,474,786 | 0.75% |
| EMERALD ADVISERS, LLC | 838,572 | $15,354,253 | 0.74% |
| DAFNA Capital Management LLC | 122,547 | $2,243,836 | 0.70% |
| SPHERA FUNDS MANAGEMENT LTD. | 193,650 | $3,545,732 | 0.65% |
| Nantahala Capital Management | 407,205 | $7,455,924 | 0.64% |
This page lists AMYLYX PHARMACEUTICALS INC's shareholders in Q3 2023. To view AMYLYX PHARMACEUTICALS INC's shareholder history, click here.